Alitair Pharmaceuticals focuses on developing innovative treatments using the 505(b)(2) approval pathway. Our patent portfolio includes treatments with low research and development costs for indications with significant unmet market needs.
Ion Exchange Resin Technology
Using ion exchange resin breakthroughs, Alitair has developed robust capabilities for a variety of therapy areas including overdose reduction technologies and cough treatments. Alitair is seeking development partners for our patented ion exchange resin technology. Contact us here to learn more about partnering with us.
Alitair currently holds the following patents:
Several additional patents are pending.